Tumor-intrinsic metabolic pathways essential for tumorigenesis and resistance to anti-PD1 in oncogenic Kras-driven lung adenocarcinoma
Abstract Immune checkpoint blockade (ICB) targeting PD-1 has transformed cancer therapy, yet many tumors display primary or acquired resistance. Metabolic interactions within the tumor microenvironment are increasingly recognized as key modulators of anti-tumor immunity. To identify tumor-intrinsic...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-03-01
|
| Серія: | Cancer & Metabolism |
| Онлайн доступ: | https://doi.org/10.1186/s40170-026-00426-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|